PLATINUM INVESTMENT MANAGEMENT LTD - ASLAN PHARMACEUTICALS LTD ownership

ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 38 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 42.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of ASLAN PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2022$87,000
+20.8%
145,5580.0%0.00%
+33.3%
Q2 2022$72,000
-45.0%
145,5580.0%0.00%
-25.0%
Q1 2022$131,000
-86.8%
145,558
-83.6%
0.00%
-85.7%
Q4 2021$993,000
-37.1%
886,8670.0%0.03%
-36.4%
Q3 2021$1,579,000
-46.1%
886,8670.0%0.04%
-35.3%
Q2 2021$2,927,000
+69.7%
886,867
+72.2%
0.07%
+78.9%
Q1 2021$1,725,000
+83.1%
514,9840.0%0.04%
+72.7%
Q4 2020$942,000
+16.0%
514,984
+20.6%
0.02%
+10.0%
Q3 2020$812,000
-2.3%
427,141
+2.8%
0.02%
+5.3%
Q2 2020$831,000
+96.0%
415,4500.0%0.02%
+72.7%
Q1 2020$424,000
-49.7%
415,4500.0%0.01%
-35.3%
Q4 2019$843,000
+17.2%
415,4500.0%0.02%
+6.2%
Q3 2019$719,000
-43.6%
415,4500.0%0.02%
-46.7%
Q2 2019$1,275,000
-23.5%
415,450
+7.0%
0.03%
-23.1%
Q1 2019$1,666,000
+62.7%
388,395
+36.5%
0.04%
+11.4%
Q4 2018$1,024,000
-54.9%
284,4950.0%0.04%
-45.3%
Q3 2018$2,270,000
-10.3%
284,4950.0%0.06%
+6.7%
Q2 2018$2,532,000284,4950.06%
Other shareholders
ASLAN PHARMACEUTICALS LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,017,971$2,066,0000.49%
DAFNA Capital Management LLC 117,682$239,0000.08%
Temasek Holdings (Private) Ltd 1,422,475$2,888,0000.02%
PLATINUM INVESTMENT MANAGEMENT LTD 415,450$843,0000.02%
Virtu Financial LLC 54,386$110,0000.01%
MARSHALL WACE, LLP 96,095$195,0000.00%
UBS Group AG 150$00.00%
DEUTSCHE BANK AG\ 2,151$4,0000.00%
MORGAN STANLEY 18,582$37,0000.00%
BANK OF MONTREAL /CAN/ 10,000$20,0000.00%
View complete list of ASLAN PHARMACEUTICALS LTD shareholders